COMP <GO>
KINS vs BRK-B // RSI-14 & 200D SMA MOMENTUM
Kingstone Companies Inc. (NASDAQ) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: KINS 5
— BRK-B 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: BRK-B
LAST: $20.17 (+0.65%) • MKT CAP: $290.1M
rsi-technicals
60.0
LAST: $542.49 (+0.10%) • MKT CAP: $1.20T
rsi-technicals
67.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KINS VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KINS | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 33.20% | 11.47% | +21.73 | KINS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.09% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 27.80% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 19.00% | 22.30% | -3.30 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 38.50% | 3.93% | +34.57 | KINS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.49% | 0.00% | +0.49 | KINS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.85 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | KINS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 3.55% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 60.0 | 67.7 | -7.70 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.61 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.0x | 24.3x | -18.34 | KINS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $290.1M | $1.20T | -$1.20T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KINS REV | BRK-B REV | KINS GROSS % | BRK-B GROSS % | KINS FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $214.9M | $371.44B | — | — | $73.1M | $25.04B |
| FY 2024 | $155.1M | $371.43B | — | — | $55.6M | $11.62B |
| FY 2023 | $144.2M | $364.48B | — | — | -$11.3M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KINS // BETA —
BRK-B // BETA 0.61